The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
Goal of providing 12-month internship opportunities for qualified students
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
It is estimated that 300 million men worldwide were affected by ED in 2020, a figure projected to increase to 322 million by 2025. Nearly 30% of these were aged between 40 and 70
The project is a collaboration between IIT Delhi and AIIMS
'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is expected to be complete in Q3FY22
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
Subscribe To Our Newsletter & Stay Updated
